Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xospata
Pharma
Daiichi scores FDA nod for leukemia med Vanflyta
Daiichi Sankyo scored a long-awaited U.S. approval for quizartinib, teeing up a showdown with drugs from Novartis and Astellas Pharma.
Fraiser Kansteiner
Jul 21, 2023 10:05am
Leqembi, Enhertu and Cipla—Fierce Pharma Asia
Mar 10, 2023 8:10am
In expansion bid, Astellas' Xospata comes up short again
Mar 9, 2023 10:11am
Astellas goes 'aggressive' with new CEO
Feb 6, 2023 11:14am
Merck-Eisai, J&J-Legend, AZ-Samsung and more—Fierce Pharma Asia
Dec 17, 2021 10:20am
Astellas finds the silver lining in failed trial for Xospata
Dec 14, 2021 2:57am
